Representing sophisticated corporate and individual clients in complex state, federal and arbitral proceedings, I resolve matters involving allegations of breach of contract, fraud, negligence, chapter 93A violations, breach of fiduciary duty, breach of the implied covenant of good faith and fair dealing, misappropriation of trade secrets, and other commercial claims. My real estate litigation practice involves representing corporations, individuals, and conservation entities in a variety of matters before the Land Court, Superior Court, and municipal boards, including boundary disputes, adverse possession, easements, trespass, zoning, and other issues.

Litigation boutique focused on representing sophisticated individuals and corporations in business disputes and real estate litigation on the North Shore and across Greater Boston.

Represented sophisticated individuals and corporations facing significant civil liability through complex litigation and arbitration in state, federal, and international forums, both in first chair and supporting roles. Served for 12 years as outside litigation counsel for a leading global biopharmaceutical services organization, representing the company in general business litigation matters; Rule 45 subpoena practice, including internal fact investigation to evaluate potential exposure, employee interviews, document holds, negotiation with requesting parties, protection of confidential information and trade secrets, and motion practice in connection with antitrust, securities, RICO, and products liability class actions, patent disputes, and qui tam litigation; and grand jury subpoena responses, including negotiation with government entities concerning scope of search, collection, and production. Gained extensive experience with industry master services agreements and related contracts; clinical trial procedures; contractual, regulatory, and corporate confidentiality considerations; and overall business operations and strategic concerns of a global, multi-billion-dollar corporation.

Representative engagements include:Represented South African technology company in international arbitration and obtained an award of over $6 million. Successfully represented property owners in an adverse possession and trespass dispute with a downhill abutting property owner in Land Court; drafted and negotiated terms of agreement for judgment resolving case.Successfully opposed motion to compel brought by Hatch-Waxman plaintiff against client, a non-party, publicly-traded clinical research organization (United Therapeutics Corp. v. Watson Labs., Inc., 200 F.Supp.3d 272 (D.Mass. 2016)).Successfully represented a hotel proprietor in a construction dispute with a general contractor. After we compelled arbitration with the general contractor under the Massachusetts Arbitration Act, the matter was resolved through mediation prior to hearing. Successfully represented international industrial materials company and its owner in parallel employment and breach of contract disputes against former employee; disputes resolved through mediation.Successfully represented petitioner for clemency in Massachusetts in 2014, obtaining one of the first pardons in the Commonwealth since 2002 for pro bono client. Successfully defended government contractor in two-year-long criminal false claims and environmental investigation by the Massachusetts Attorney General’s Office, ultimately resolved by a civil settlement.Successfully represented seed investors in breach of contract and breach of fiduciary duty litigation against hedge fund manager; multi-million dollar settlement reached after jury empaneled.Successfully represented a marketing vendor in a RICO class action alleging illegal off-label promotion of antipsychotic medication. The matter was resolved on motion to dismiss, which was upheld on appeal (Ironworkers Local Union 68 v. AstraZeneca Pharm., LP, 634 F.3d 1352 (11th Cir. 2011)).

Co-taught a section of undergraduate environmental law course during the spring semester of my 3L year.

Account Executive, Corporate and Financial Communications Practice, March – July 2004Account Executive, Healthcare and Pharmaceutical Practice, April 2003 – February 2004Researched, developed, and presented strategic communications plans to prospective major pharmaceutical clients; Strategic outreach to healthcare and trade reporters concerning clinical study data and client initiatives;Fielded calls from fund managers, analysts, and investors for major telecommunications client during Chapter 11 proceedings.

Account Executive, Healthcare Practice, April 2002 – March 2003Represented major pharmaceutical company on high-level, practitioner-focused campaigns in support of atypical antipsychotic franchise;Analyzed competitor presentations and materials from major medical conferences to compare messaging and determine communications strategy;Researched third-party groups for potential strategic partnerships.